<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230710058738N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-08-22</date_registration>
      <primary_sponsor>Yazd University of Medical Sciences</primary_sponsor>
      <public_title>Sexual health empowerment model versus DEEP model (Natural Differences, Emotional Sensitivities, External Stressors, Patterns of Communication) on sexual function and attitude and performance of condom use in Papillomavirus infected women</public_title>
      <acronym></acronym>
      <scientific_title>The effectiveness comparison of sexual health empowerment model via DEEP model (Natural Differences, Emotional Sensitivities, External Stressors, Patterns of Communication) on sexual function and attitude and performance of condom use in papillomavirus infected women</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-10-02</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>68</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/71284</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Randomization description: Eligible women, referring to Baqaeipour clinic in Yazd, are recruited according to the criteria of participating in the study. Convenience sampling is used. The ones with size 4 are obtained using the software www.random.org/sequences. Each woman is given a number between 1to 68. The women will be allocated in two groups DEEP model or Sexual health empowerment model (34 women in each group). Allocation concealment is used, so no women and researcher don't know each woman will allocate to each group.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Human Papilloma Virus.</hc_freetext>
      <i_freetext>Intervention 1: The first intervention group: The first group will receive the DEEP model in the form of 8 online and consecutive sessions, once a week for 90 minutes, by the second researcher, a senior midwife counseling student who has completed the sexual disorders course and obtained the necessary certificate, under the supervision of the first researcher, the supervisor (reproductive health specialist and clinical psychologist) and the third researcher, the consultant professor (reproductive health specialist) will be held in the sky room. The content of the sessions will be in the format of educational videos, PowerPoint presentations, and questions and answers. At the beginning of each session, a summary of the contents of the previous sessions will be reviewed, and the assignments related to the previous session will be reviewed by the first and second researcher to measure their improvement in each session. Women are asked to participate in counseling discussions and raise their questions. The second researcher will ask questions about the topics of the meeting for the participation of more people in the meeting. To learn more, the relevant educational video will also be presented to them. At the end of each meeting, a summary of the important topics mentioned is presented and the questions of the people are answered, and the women are asked to do their homework until the next meeting. The content of the sessions of the DEEP model includes the description of the Deep model and the conceptualization of each word, pair evaluation, teaching strategies for acceptance, empathic attachment and creating empathy, controlling external factors, creating tolerance, creating change, and more preparation. Intervention 2: The second intervention group: the second group (control group) will receive the Sexual Health Empowerment model in the form of 8 online and consecutive sessions, once a week for 90 minutes, by the second researcher, a senior midwife counseling student who has completed the sexual disorders course and obtained the necessary certificate, under the supervision of the first researcher, the supervisor (reproductive health specialist and clinical psychologist) and the third researcher, the consultant professor (reproductive health specialist) will be held in the sky room. The content of the sessions will be in the format of educational videos, PowerPoint presentations, and questions and answers. At the beginning of each session, a summary of the contents of the previous sessions will be reviewed, and the assignments related to the previous session will be reviewed by the first and second researcher to measure their improvement in each session. Women are asked to participate in counseling discussions and raise their questions. The second researcher will ask questions about the topics of the meeting for the participation of more people in the meeting. To learn more, the relevant educational video will also be presented to them. At the end of each meeting, a summary of the important topics mentioned is presented and the questions of the people are answered, and the women are asked to do their homework until the next meeting.The content of the Sexual Health Empowerment model sessions includes getting to know this concept and its goals, recognizing and adapting to physiological and sexual differences in couples, correcting false beliefs and changing attitudes, explaining sexual concerns in these couples, learning skills to communicate effectively and negotiate with each other, to resolve conflicts and reduce risky behaviors, description of marital intimacy and its dimensions.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All individual data of study participants can be shared after de-identification.

When:
After publishing the results

To whom:
The data will be available to researchers working in academic and scientific institutions, and people working in industry can apply to receive them.

Conditions:
Scientific application

Where to obtain:
farajkhoda_t@yahoo.com

How to obtain:
One week after receiving the applicant's email

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Tahmineh Farajkhoda</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Bu Ali St</address>
        <city>Yazd</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۸۹۱۶۸۷۷۴۴۳</zip>
        <telephone>+98 35 3824 1751</telephone>
        <email>farajkhoda_t@yahoo.com</email>
        <affiliation>Yazd University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Tahmineh Farajkhoda</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Bu Ali St</address>
        <city>Yazd</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۸۹۱۶۸۷۷۴۴۳</zip>
        <telephone>+98 35 3824 1751</telephone>
        <email>farajkhoda_t@yahoo.com</email>
        <affiliation>Yazd University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Having a medical record of being infected with papillomavirus (infection with low-risk or high-risk types of the virus and type 1 and 2 dysplasia) at Baghaeipour Clinic in Yazd, diagnosed by the  physician
Women in reproductive age (15 to 49 years)
Being married
Having sufficient sexual intercourse with the spouse in the past 4 weeks
Willingness to participate in the study
Owning an Android or iOS smartphone
Being able to use online counseling via a smartphone
Literacy in reading and writing
Proficiency in speaking Persian
Sexual dysfunction</inclusion_criteria>
      <agemin>15 years</agemin>
      <agemax>49 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Pregnancy
Condom use
Diagnosis of psychological disorders in the past year according to women's statements
Participation in similar studies
Occurrence of stressful events during participation in the study (such as the death of family members or divorce)
Addiction to drugs and alcohol
Patients with hearing problems</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>B97.7</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Papillomavirus as the cause of diseases classified elsewhere</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Behavior</i_code>
      <i_code>Behavior</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>The first intervention group: The first group will receive the DEEP model in the form of 8 online and consecutive sessions, once a week for 90 minutes, by the second researcher, a senior midwife counseling student who has completed the sexual disorders course and obtained the necessary certificate, under the supervision of the first researcher, the supervisor (reproductive health specialist and clinical psychologist) and the third researcher, the consultant professor (reproductive health specialist) will be held in the sky room. The content of the sessions will be in the format of educational videos, PowerPoint presentations, and questions and answers. At the beginning of each session, a summary of the contents of the previous sessions will be reviewed, and the assignments related to the previous session will be reviewed by the first and second researcher to measure their improvement in each session. Women are asked to participate in counseling discussions and raise their questions. The second researcher will ask questions about the topics of the meeting for the participation of more people in the meeting. To learn more, the relevant educational video will also be presented to them. At the end of each meeting, a summary of the important topics mentioned is presented and the questions of the people are answered, and the women are asked to do their homework until the next meeting. The content of the sessions of the DEEP model includes the description of the Deep model and the conceptualization of each word, pair evaluation, teaching strategies for acceptance, empathic attachment and creating empathy, controlling external factors, creating tolerance, creating change, and more preparation.</i_keyword>
      <i_keyword>The second intervention group: the second group (control group) will receive the Sexual Health Empowerment model in the form of 8 online and consecutive sessions, once a week for 90 minutes, by the second researcher, a senior midwife counseling student who has completed the sexual disorders course and obtained the necessary certificate, under the supervision of the first researcher, the supervisor (reproductive health specialist and clinical psychologist) and the third researcher, the consultant professor (reproductive health specialist) will be held in the sky room. The content of the sessions will be in the format of educational videos, PowerPoint presentations, and questions and answers. At the beginning of each session, a summary of the contents of the previous sessions will be reviewed, and the assignments related to the previous session will be reviewed by the first and second researcher to measure their improvement in each session. Women are asked to participate in counseling discussions and raise their questions. The second researcher will ask questions about the topics of the meeting for the participation of more people in the meeting. To learn more, the relevant educational video will also be presented to them. At the end of each meeting, a summary of the important topics mentioned is presented and the questions of the people are answered, and the women are asked to do their homework until the next meeting.The content of the Sexual Health Empowerment model sessions includes getting to know this concept and its goals, recognizing and adapting to physiological and sexual differences in couples, correcting false beliefs and changing attitudes, explaining sexual concerns in these couples, learning skills to communicate effectively and negotiate with each other, to resolve conflicts and reduce risky behaviors, description of marital intimacy and its dimensions.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Sexual function (primary outcome variable). Timepoint: Baseline, completion of the intervention in the eighth week and follow-up at the end of the study in the twelfth week. Method of measurement: Rosen et al Sexual Functioning Questionnaire (1997).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Attitude toward condom use (Secondary outcome variable). Timepoint: Baseline, completion of the intervention in the eighth week and follow-up at the end of the study in the twelfth week. Method of measurement: Attitude of Condom Use Questionnaire.</sec_outcome>
      <sec_outcome>The frequency of condom use (Secondary outcome variable). Timepoint: Baseline, completion of the intervention in the eighth week and follow-up at the end of the study in the twelfth week. Method of measurement: Performance of Condom Use Questionnaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Yazd University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-07-12</approval_date>
        <contact_name>Research Ethics Committee of Shahid Sadoughi University of Medical Sciences, Yazd</contact_name>
        <contact_address>Bahonar Square, Yazd Yazd Yazd Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
